A Study of Takhzyro in Teenagers and Adults With Hereditary Angioedema (HAE) in South Korea

Starting soon

Conditions studied: Hereditary Angioedema (HAE)

In brief

Takhzyro is an approved treatment for hereditary angioedema (HAE) in South Korea. HAE is a rare condition which causes sudden swelling under the skin and inside the body, like in the belly, throat, or genitals. The main aim of this study is to check how safe Takhzyro is in teenagers and adults with HAE in everyday medical care in South Korea. Another aim is to see how well Takhzyro works in everyday medical care. The treatment of participants and any check-ups will be determined by the treating doctors according to their normal practice. Participants may visit the study clinic several times during the study.

Key facts

Study ID

NCT07445087

Run by

Takeda

People needed

35

Starts

2026-10-01

Expected to finish

2032-02-29

Last updated by the study team

2026-06-18

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants aged 12 years or older at time of initiation of Takhzyro.
• Participants who are treated or will be treated with Takhzyro according to the approved label of South Korea.
• The participant or legally authorized representative agrees to participate.

You may not qualify if…

• Any of the contraindications included in the Prescribing Information (PI) for TAKHZYRO apply.
• Participant is currently enrolled in an interventional trial.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.